Johnson & Johnson
third-quarter adjusted earnings topped analysts’ estimates however the healthcare large reduce its gross sales steering for the yr.
Johnson & Johnson
(ticker: JNJ) posted adjusted earnings of $2.fifty five a share on gross sales of $23.eight billion.
0 Comments